KAKEN PHARMACEUTICAL CO.,LTD. 4521Short Interest

No institution currently reports a short position of 0.5% or more in KAKEN PHARMACEUTICAL CO.,LTD. (4521). The last disclosure was on 2026-09-15 (BNP Paribas Financial Markets SNC, 0.39%).

Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
30 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 5 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2021-05-13
Latest disclosure2026-09-15 (BNP Paribas Financial Markets SNC, 0.39%)
Reporting institutions5 firms (30 reports)
Peak estimated short interest1.03% (2021-05-25, 2 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 4 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • J.P. MORGAN SECURITIES PLC
  • Citigroup Global Markets Limited
  • BNP Paribas Financial Markets SNC
  • Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2021-06-02 GOLDMAN SACHS INTERNATIONAL Position 218,765 shares Ratio 0.47% ▼0.05% −22,299 Below 0.5%
2025-06-20 J.P. MORGAN SECURITIES PLC Position 211,507 shares Ratio 0.47% ▼0.03% −10,400 Below 0.5%
2026-09-15 BNP Paribas Financial Markets SNC Position 173,500 shares Ratio 0.39% ▼0.19% −85,600 Below 0.5%
2023-08-30 Integrated Core Strategies (Asia) Pte. Ltd. Position 172,703 shares Ratio 0.37% ▼0.14% −64,737 Below 0.5%
2026-07-31 Citigroup Global Markets Limited Position 64,835 shares Ratio 0.14% ▼0.39% −173,100 Below 0.5%

Disclosure History 30 in total

Trade date Short seller Position (shares) Ratio Change Note
2026-09-15 BNP Paribas Financial Markets SNC Position 173,500 shares Ratio 0.39% ▼0.19% −85,600 Below 0.5%
2026-09-14 BNP Paribas Financial Markets SNC Position 259,100 shares Ratio 0.58% ▲0.58% +150,100 —
2026-07-31 Citigroup Global Markets Limited Position 64,835 shares Ratio 0.14% ▼0.39% −173,100 Below 0.5%
2026-07-29 Citigroup Global Markets Limited Position 237,935 shares Ratio 0.53% ▲0.11% +107,246 —
2026-07-17 Citigroup Global Markets Limited Position 130,689 shares Ratio 0.29% ▼0.24% −107,500 Below 0.5%
2026-07-15 Citigroup Global Markets Limited Position 238,189 shares Ratio 0.53% ▼0.11% −45,500 —
2026-07-08 Citigroup Global Markets Limited Position 283,689 shares Ratio 0.64% ▲0.05% +20,900 —
2026-07-07 Citigroup Global Markets Limited Position 262,789 shares Ratio 0.59% ▲0.25% +65,046 —
2026-05-27 BNP Paribas Financial Markets SNC Position 109,000 shares Ratio 0.24% ▼0.28% −122,000 Below 0.5%
2026-05-22 BNP Paribas Financial Markets SNC Position 231,000 shares Ratio 0.52% ▲0.52% —
2026-02-17 Citigroup Global Markets Limited Position 197,743 shares Ratio 0.44% ▼0.13% −54,900 Below 0.5%
2026-02-12 Citigroup Global Markets Limited Position 252,643 shares Ratio 0.57% ▼0.11% −49,300 —
2026-02-09 Citigroup Global Markets Limited Position 301,943 shares Ratio 0.68% ▼0.02% −10,800 —
2026-02-06 Citigroup Global Markets Limited Position 312,743 shares Ratio 0.70% ▲0.03% +13,300 —
2026-02-05 Citigroup Global Markets Limited Position 299,443 shares Ratio 0.67% ▲0.11% +50,000 —
2026-02-04 Citigroup Global Markets Limited Position 249,443 shares Ratio 0.56% ▲0.13% —
2025-06-20 J.P. MORGAN SECURITIES PLC Position 211,507 shares Ratio 0.47% ▼0.03% −10,400 Below 0.5%
2025-06-18 J.P. MORGAN SECURITIES PLC Position 221,907 shares Ratio 0.50% ▲0.01% +2,700 —
2025-06-12 J.P. MORGAN SECURITIES PLC Position 219,207 shares Ratio 0.49% ▼0.01% −1,500 Below 0.5%
2025-06-10 J.P. MORGAN SECURITIES PLC Position 220,707 shares Ratio 0.50% ▲0.01% +4,300 —
2025-06-03 J.P. MORGAN SECURITIES PLC Position 216,407 shares Ratio 0.49% ▼0.35% −158,500 Below 0.5%
2025-06-02 J.P. MORGAN SECURITIES PLC Position 374,907 shares Ratio 0.84% ▲0.44% —
2023-08-30 Integrated Core Strategies (Asia) Pte. Ltd. Position 172,703 shares Ratio 0.37% ▼0.14% −64,737 Below 0.5%
2023-08-15 Integrated Core Strategies (Asia) Pte. Ltd. Position 237,440 shares Ratio 0.51% ▲0.10% +177,340 —
2021-06-02 GOLDMAN SACHS INTERNATIONAL Position 218,765 shares Ratio 0.47% ▼0.05% −22,299 Below 0.5%
2021-05-27 Integrated Core Strategies (Asia) Pte. Ltd. Position 60,100 shares Ratio 0.13% ▼0.38% −177,700 Below 0.5%
2021-05-25 Integrated Core Strategies (Asia) Pte. Ltd. Position 237,800 shares Ratio 0.51% ▲0.10% —
2021-05-25 GOLDMAN SACHS INTERNATIONAL Position 241,064 shares Ratio 0.52% ▲0.08% +37,199 —
2021-05-18 GOLDMAN SACHS INTERNATIONAL Position 203,865 shares Ratio 0.44% ▼0.06% −28,100 Below 0.5%
2021-05-13 GOLDMAN SACHS INTERNATIONAL Position 231,965 shares Ratio 0.50% ▲0.09% —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector

Stock Market TSE 33 Sector TOPIX-17 Sector Index
Sumitomo Pharma Co.,Ltd.4506 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
Shionogi & Co.,Ltd.4507 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Large70
WAKAMOTO PHARMACEUTICAL CO.,LTD.4512 Standard Market(Domestic) Pharmaceutical Pharmaceutical
Nippon Shinyaku Co.,Ltd.4516 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
CHUGAI PHARMACEUTICAL CO.,LTD.4519 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Large70
Eisai Co.,Ltd.4523 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
ROHTO PHARMACEUTICAL CO.,LTD.4527 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
ONO PHARMACEUTICAL CO.,LTD.4528 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
SANTEN PHARMACEUTICAL CO.,LTD.4536 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
Fuso Pharmaceutical Industries,Ltd.4538 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2